|
May 10
|
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
|
|
May 10
|
Consumer sentiment drops, Tesla's Supercharger, Zeekr IPO: Catalysts
|
|
May 10
|
Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine
|
|
May 10
|
Moderna: FDA postpones RSV vaccine approval
|
|
May 10
|
Moderna's RSV Vaccine Review Delayed by FDA to End of May
|
|
May 10
|
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
|
|
May 10
|
FDA delays decision on Moderna RSV vaccine
|
|
May 10
|
US FDA pushes decision on Moderna's RSV vaccine to end of this month
|
|
May 10
|
Moderna Announces Update on Investigational RSV Vaccine
|
|
May 9
|
Moderna's Promise of mRNA Undercut by New RSV Vaccine
|
|
May 9
|
Sisk selected for MITC fit-out in Oxfordshire
|
|
May 9
|
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
|
|
May 9
|
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past year
|
|
May 9
|
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
|
|
May 5
|
Largest U.S. Pension Sold Verizon, Disney, and Peloton Stock. It Bought Moderna.
|
|
May 4
|
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
|
|
May 4
|
Analysts Are Updating Their Moderna, Inc. (NASDAQ:MRNA) Estimates After Its First-Quarter Results
|
|
May 4
|
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
|
|
May 3
|
Moderna First Quarter 2024 Earnings: Beats Expectations
|
|
May 3
|
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
|